The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow A correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sa, S. M.
Right arrow Articles by Ouyang, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sa, S. M.
Right arrow Articles by Ouyang, W.
The Journal of Immunology, 2007, 178: 2229-2240.
Copyright © 2007 by The American Association of Immunologists, Inc.

The Effects of IL-20 Subfamily Cytokines on Reconstituted Human Epidermis Suggest Potential Roles in Cutaneous Innate Defense and Pathogenic Adaptive Immunity in Psoriasis

Susan M. Sa*, Patricia A. Valdez{dagger}, Jianfeng Wu{dagger}, Kenneth Jung{ddagger}, Fiona Zhong*, Linda Hall*, Ian Kasman*, Jane Winer§, Zora Modrusan§, Dimitry M. Danilenko1,* and Wenjun Ouyang1,{dagger}

* Department of Pathology, {dagger} Department of Immunology, {ddagger} Department of Bioinformatics, and § Department of Molecular Biology, Genentech, South San Francisco, CA 94080

IL-19, IL-20, IL-22, IL-24, and IL-26 are members of the IL-10 family of cytokines that have been shown to be up-regulated in psoriatic skin. Contrary to IL-10, these cytokines signal using receptor complex R1 subunits that are preferentially expressed on cells of epithelial origin; thus, we henceforth refer to them as the IL-20 subfamily cytokines. In this study, we show that primary human keratinocytes (KCs) express receptors for these cytokines and that IL-19, IL-20, IL-22, and IL-24 induce acanthosis in reconstituted human epidermis (RHE) in a dose-dependent manner. These cytokines also induce expression of the psoriasis-associated protein S100A7 and keratin 16 in RHE and cause persistent activation of Stat3 with nuclear localization. IL-22 had the most pronounced effects on KC proliferation and on the differentiation of KCs in RHE, inducing a decrease in the granular cell layer (hypogranulosis). Furthermore, gene expression analysis performed on cultured RHE treated with these cytokines showed that IL-19, IL-20, IL-22, and IL-24 regulate many of these same genes to variable degrees, inducing a gene expression profile consistent with inflammatory responses, wound healing re-epithelialization, and altered differentiation. Many of these genes have also been found to be up-regulated in psoriatic skin, including several chemokines, beta-defensins, S100 family proteins, and kallikreins. These results confirm that IL-20 subfamily cytokines are important regulators of epidermal KC biology with potentially pivotal roles in the immunopathology of psoriasis.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Address correspondence and reprint requests to Dr. Wenjun Ouyang, Department of Immunology, Genentech, 1 DNA Way, MS 34, South San Francisco, CA 94080; E-mail address: ouyang{at}gene.com or Dr. Dimitry M. Danilenko, Genentech, 1 DNA Way, MS 72B, South San Francisco, CA 94080; E-mail address: danilenko.dimitry{at}gene.com

2 Abbreviations used in this paper: KC, keratinocyte; CK16, cytokeratin 16; EGF, epidermal growth factor; EGFR, EGF receptor; HB, heparin binding; IHC, immunohistochemistry; KGF, KC growth factor; NHEK, normal human epidermal KC; pY, phosphotyrosine; RefSeq, reference sequence; RHE, reconstituted human epidermis; VEGF, vascular endothelial growth factor.

3 The online version of this article contains supplemental material.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
G. Tjabringa, M. Bergers, D. van Rens, R. de Boer, E. Lamme, and J. Schalkwijk
Development and Validation of Human Psoriatic Skin Equivalents
Am. J. Pathol., September 1, 2008; 173(3): 815 - 823.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
D. M. Danilenko
Review Paper: Preclinical Models of Psoriasis
Vet. Pathol., July 1, 2008; 45(4): 563 - 575.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
N. Sakurai, T. Kuroiwa, H. Ikeuchi, N. Hiramatsu, A. Maeshima, Y. Kaneko, K. Hiromura, and Y. Nojima
Expression of IL-19 and its receptors in RA: potential role for synovial hyperplasia formation
Rheumatology, June 1, 2008; 47(6): 815 - 820.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. Wolk, K. Witte, E. Witte, S. Proesch, G. Schulze-Tanzil, K. Nasilowska, J. Thilo, K. Asadullah, W. Sterry, H.-D. Volk, et al.
Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytes
J. Leukoc. Biol., May 1, 2008; 83(5): 1181 - 1193.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
L. C. Zaba, I. Cardinale, P. Gilleaudeau, M. Sullivan-Whalen, M. Suarez-Farinas, J. Fuentes-Duculan, I. Novitskaya, A. Khatcherian, M. J. Bluth, M. A. Lowes, et al.
Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses
J. Exp. Med., December 24, 2007; 204(13): 3183 - 3194.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.